Assessment and Impact of Phase Angle and Sarcopenia in Palliative Cancer Patients

References

• Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, et al.: Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 3, 260, 2012.
   PubMed Web of Science ®Google Scholar
• Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, et al.: Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55, 769–774, 2007.
   PubMed Web of Science ®Google Scholar
• Rosenberg I: Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 50, 1231–1233, 1989.
   Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Landi F, Topinkova E, and Michel JP: Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13, 1e7, 2010.
   Web of Science ®Google Scholar
• Cruz Jentoft A, Pierre Bayens J, Baüer J, Boirie Y, Cederholm T, et al.: Sarcopenia: European consensus on definition and diagnosis/report of the European working group on sarcopenia in older people. Age Ageing 39, 412–423, 2010.
   PubMed Web of Science ®Google Scholar
• Tisdale MJ: Pathogenesis of cancer cachexia. J Support Oncol 1, 159–168, 2003.
   PubMedGoogle Scholar
• Cruz-Jentoft AJ, Landi F, Schneider SM, Zuñiga C, Arai H, et al.: Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43, 748e759, 2014.
   Web of Science ®Google Scholar
• Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, et al.: Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15, 2920–2926, 2009.
   PubMed Web of Science ®Google Scholar
• Awad S, Tan BH, Cui H, Bhalla A, Fearon KC, et al.: Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 31, 74–77, 2012.
   PubMed Web of Science ®Google Scholar
• Lieffers JR, Bathe OF, Fassbender K, Winget M, and Baracos VE: Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107, 931–936, 2012.
   PubMed Web of Science ®Google Scholar
• Zhang G, Xiujiang L, Changping S, Zhao H, Jihong Z, et al.: Incidence and risk factor analysis for sarcopenia in patients with cancer. Oncol Lett 11, 1230–1234, 2016.
   PubMed Web of Science ®Google Scholar
• Min Kim K, Chul Jang H, and Lim S: Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med 31, 643–650, 2016.
   PubMed Web of Science ®Google Scholar
• Barbosa Silva MC, and Barros AJ: Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 3, 311–317, 2005.
   Web of Science ®Google Scholar
• Basile C, Della-Morte D, Cacciatore F, Gargiulo G, Galizia G, et al.: Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia. Exp Gerontol 58, 43–46, 2014.
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, and Ross R: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50, 889–896, 2002.
   PubMed Web of Science ®Google Scholar
• Chien MY, Huang TY, and Wu YT: Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 56 (9), 1710–1715, 2008.
   PubMed Web of Science ®Google Scholar
• Collins J, Noble S, Chester J, Coles B, and Byrne A: The assessment and impact of sarcopenia in lung cancer: a systematic literature review. BMJ Open 4 (1), e003697, 2014.
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, Baumgartner RN, and Ross R: Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89, 465–471, 2000.
   PubMed Web of Science ®Google Scholar
• Janssen I, Baumgartner R, Ross R, Rosenberg IH, and Roubenoff R: Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159, 413–421, 2004.
   PubMed Web of Science ®Google Scholar
• Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, and Antoun S: Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 91, 1133S–1137S, 2010.
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al.: Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31, 1539–1547, 2013.
   PubMed Web of Science ®Google Scholar
• Norman K, Stobäus N, Pirlich M, and Bosy-Westphal A: Bioelectrical phase angle and impedance vector analysis – clinical relevance and applicability of impedance parameters. Clin Nutr 6, 854–861, 2012.
   Web of Science ®Google Scholar
• Paiva SI, Borges LR, Halpern-Silveira DA, Assuncao MC, Barros AJ, et al.: Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 19, 187–192, 2011.
   Web of Science ®Google Scholar
• Yeon Lee S, Joo Lee Y, Yang JH, Kim CM, and Choi WS: The association between phase angle of bioelectrical impedance analysis and survival time in advanced cancer patients: preliminary study. Korean J Fam Med 35, 251–256, 2014.
   PubMedGoogle Scholar
• Hui D, Bansal S, Morgado M, Dev R, Chisholm G, et al.: Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer 14, 2207–2214, 2014.
   Web of Science ®Google Scholar
• Grundmann O, Yoon SL, and Williams JJ: The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients–a comprehensive review. Eur J Clin Nutr 69 (12), 1290–1297, 2015.
   PubMed Web of Science ®Google Scholar
• Stegel P, Kozjek NR, Brumen BA, and Strojan P: Bioelectrical impedance phase angle as indicator and predictor of cachexia in head and neck cancer patients treated with (chemo)radiotherapy. Eur J Clin Nut 70 (5), 602–606, 2016.
   PubMed Web of Science ®Google Scholar
• Ozorio GA, Barão K, and Forones NM: Cachexia stage, patient-generated subjective global assessment, phase angle, and handgrip strength in patients with gastrointestinal cancer. Nutr Cancer 69 (5), 772–779, 2017.
   PubMed Web of Science ®Google Scholar
• Pérez Camargo DA, Allende Pérez SR, Rivera Franco MM, Álvarez Licona NE, Urbalejo Ceniceros VI, et al.: Phase angle of bioelectrical impedance analysis as prognostic factor in palliative care patients at the national cancer institute in Mexico. Nutr Cancer 69 (4), 601–606, 2017.
   PubMed Web of Science ®Google Scholar
• Kim EY, Kim K, Kim YS, Ahn HK, Jeong YM, et al.: Prevalence of and factors associated with sarcopenia in Korean cancer survivors: based on data obtained by the Korea National Health and Nutrition Examination Survey (KNHANES) 2008–2011. Nutr Cancer 69 (3), 394–401, 2017.
   PubMed Web of Science ®Google Scholar
• Morishita S: Prevalence of sarcopenia in cancer patients: review and future directions. Int J Phys Med Rehabil 4, 342, 2016.
   Google Scholar
• Rutten IJ, Ubachs J, Kruitwagen RF, van Dijk DP, Beets-Tan RG, et al.: The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery. Eur J Surg Oncol 43 (4), 717–724, 2017.
   PubMed Web of Science ®Google Scholar
• Fukushima H, and Koga F: Impact of sarcopenia in the management of urological cancer patients. Expert Rev Anticancer Therapy 17 (5), 1–12, 2017.
   PubMed Web of Science ®Google Scholar
• Kudou K, Saeki H, Nakashima Y, Edahiro K, Korehisa S, et al.: Prognostic significance of sarcopenia in patients with Esophagogastric junction cancer or upper gastric cancer. Ann Surg Oncol 24(7), 1804–1810, 2017. doi: 10.1245/s10434-017-5811-9.
   PubMed Web of Science ®Google Scholar